The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy
暂无分享,去创建一个
Y. Baskın | I. Oztop | H. Ellidokuz | T. Akman | O. Unal | U. Oflazoglu | M. Akbarpour | U. Oflazoğlu
暂无分享,去创建一个
Y. Baskın | I. Oztop | H. Ellidokuz | T. Akman | O. Unal | U. Oflazoglu | M. Akbarpour | U. Oflazoğlu